Esophageal cancer is one of the leading causes of cancer-related death worldwide. In the Asia-Pacific region, including Japan, the vast majority of esophageal cancers are squamous cell carcinomas (SCC), for which alcohol drinking and cigarette smoking are well-known risk factors.^[@B1])^ In contrast, in western countries, esophageal SCC is rare and most esophageal cancers are adenocarcinoma in the lower portion of the thoracic esophagus, the major risk factors for which are cigarette smoking and Barrett's esophagus, which develops in approximately 5%--8% of patients with gastroesophageal reflux disease.^[@B2])^ Although pathological findings and biologic behavior differ between SCC and adenocarcinoma, surgery plays an important role in achieving locoregional control in the treatment strategies for both types of esophageal carcinoma. Surgical treatment of esophageal cancer consists of esophagectomy, two- or three-field lymphadenectomy and reconstruction using certain organs such as the stomach. Recent advances in surgical techniques and perioperative management have enabled us to perform one-stage esophagectomy with two- or three-field lymphadenectomy followed by reconstruction for patients with esophageal cancer, which dramatically improved the mortality rate; however, esophagectomy remains a highly invasive procedure that can lead to severe postoperative complications.^[@B3])^

Esophagectomy was originally performed by thoracotomy and open laparotomy, and those approaches are still selected as a standard operative procedure for some cases or in some institutions. Thoracoscopic surgery with or without the laparoscopic approach has been developed as a minimally invasive surgery for esophageal cancer; however, its advantages with regard to short-term outcomes and the oncological feasibility of minimally invasive esophagectomy have not been adequately established.^[@B4])^ Although the non-inferiority of thoracoscopic esophagectomy to open esophagectomy in terms of overall survival for clinical Stage I--III esophageal cancer is currently being investigated in a multi-institutional randomized Phase III trial (JCOG1409) in Japan,^[@B5])^ thoracoscopic surgery is becoming a major method for esophagectomy with lymphadenectomy for patients with esophageal cancer in developed countries including Japan.

Recent advances in thoracoscopic surgery with the development of surgical endoscopy systems have helped us to understand the microscopic anatomy of the thoracic cavity and mediastinum, and perform fine operations with mediastinal lymphadenectomy. Currently, three-dimensional (3D) imaging systems with a digital 3D full high-definition (HD) camera and 2D imaging systems with a 4K ultra HD (UHD) camera are available for thoracoscopic surgery, which provide real images in surgical fields and allow surgeons to observe fine patterns and structures in high precision. In future, 3D imaging systems with a 4K UHD camera will be developed, which will enable us to further understand the microscopic anatomy and to perform fine and safe operations. In the vast majority of current 3D imaging systems, surgeons need to wear 3D glasses to see a slightly different picture on screen by each eye, which decreases light and causes somewhat dim images (**[Fig. 1](#F1){ref-type="fig"}**). Because 4K UHD generates a wider color gamut by adopting the 4K color format, which enables rich color reproducibility and light images on screen, future 3D imaging systems with 4K UHD may overcome the limitations of current 3D imaging systems. Furthermore, glasses-free 3D display systems have been developed and will be widely available in the near futre. In addition, downsizing of the 8K camera has been exploited and future surgical endosopy may be equipped with an 8K camera, which is expected to provide 3D-like visual sensation even with 2D imaging systems. A robot-assisted thoracoscopic esophagectomy using the Da Vinci surgical system has also been performed in many institutions and is reportedly feasible for performing an effective lymphadenectomy.^[@B6]--[@B8])^ The 3D effect of the field of view and articulated forceps of the Da Vinc surgical system are thought to enable delicate surgical procedures. Although a robot-assisted thoracoscopic esophagectomy is attractive for surgeons and may be beneficial to esophageacl cancer patients, its cost is a matter of great concern, and special training is necessary for the use of the Da Vinc surgical system. As several campanies are developing robot-assisted surgical systems other than the Da Vinc, further technical development of surgical systems and decreased costs are to be expected in the future.
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Recently, single-port mediastinoscope-assisted transhiatal esophagectomy with lymphadenectomy has been developed as a minimally invasive surgery for thoracic esophageal cancer that can reportedly be applied to patients with low pulmonary function (**[Fig. 2](#F2){ref-type="fig"}**).^[@B9],[@B10])^ Although special skills are needed to safely perform this surgical procedure as a curative operation without complications such as recurrent laryngeal nerve paralysis, future development of surgical instruments and intraoperative recurrent laryngeal nerve monitoring may enable us to more safely perform this surgical procedure. Robot-assisted surgical systems will also help perform delicate and safe single-port mediastinoscope-assisted transhiatal esopagectomy with lymphadenectomy. However, oncological outcomes of single-port mediastinoscopeassisted transhiatal esophagectomy need to be investigated in future studies.
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Preoperative simulation for vessels such as bronchial arteries using three-dimensional computed tomographic angiography (3D-CTA) is useful to understand vessel anatomy, which we need to take care during esophagectomy to avoid tracheobronchial ischemia and unexpected massive bleeding (**[Fig. 3](#F3){ref-type="fig"}**).^[@B11])^ Furthermore, intraoperative real-time navigation is expected to further help surgeons safely perform esophagectomy with lymphadenectomy. A magnetic resonance imaging (MRI)-guided robotassisted interventional surgical system as well as an MRI-compatible endoscope are reported to allow the performance of precise image-guided interventional therapy and endoscopic surgery.^[@B12])^ To identify esophageal lesion localization, the usefulness of laparoscopic ultrasonography using endoscopically placed marking clips (LUEMC) in esophageal cancer patients undergoing minimally invasive esophagectomy was reported.^[@B13])^ Although intraoperative real-time navigation systems are investigated in some clinical studies, those are preliminary models and further studies are needed to develop clinically available real-time navigation systems. In addition to preoperative anatomical simulation and intraoperative navigation for each patient, virtual reality (VR) simulators present a new paradigm in surgical education and may provide an alternative means of improving performance in thoracoscopic surgery.^[@B14])^
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Because esophagectomy with radical lymphadenectomy is a highly invasive operation with a relatively high morbidity rate, reduction of lymphadenectomy area may be indicated for some patients with limited stage of esophageal cancer. Recently, the sentinel node (SN) concept was successfully validated for early gastric cancer through a multicenter prospective trial that mapped SNs using a dualtracer method with a radioactive colloid and blue dye.^[@B15])^ In gastric cancer treatment, mapping of the distribution of sentinel lymphatic basins with their pathological status could be useful in determining whether minimal degree of gastric resection is feasible.^[@B16])^ In contrast, SNs in thoracic esophageal cancer are widely distributed from cervical to abdominal areas.^[@B17]--[@B20])^ Because esophageal cancer is a very aggressive disease and advanced esophageal cancer frequently shows muitiple lymph node metastases, SN navigation may be indicated for cT1N0 esophageal cancers. A previous study showed that approximately 85% of pT1 patients had no lymph node metastasis or had lymph node metastasis only in SNs, and that radio-guided SN mapping is useful not only as an accurate diagnostic tool for detecting lymph node metastasis but also as a tool for prognostic stratification in patients with cN0 early-stage esophageal cancer.^[@B19])^ Because of the wide distribution of SNs and the unpredictable pattern of metastasis, esophagectomy with extended lymphadenectomy appears to be a reasonable procedure for thoracic esophageal cancer; however, optimized and individualized prophylactic nodal irradiation targeting SNs might be effective in controlling superficial cN0 esophageal SCC by chemoradiation therapy (CRT) for patients who refused esophagectomy.^[@B19])^ Although further studies are needed, reduction of the lymphadenectomy field and setting of lymphadenectomy areas with highest priority may be feasible when SN navigation is appropriately performed in cN0 early-stage esophageal cancer.

In conclusion, future development of thoracoscope and robotic surgical systems will help us further understand microscopic anatomy and perform delicate surgical procedures that enable minimally invasive esophagectomy. Preoperative simulation and intraoperaative navigation may also help surgeons safely perform esophagectomy with lymphadenectomy. SN mapping and SN navigation surgery would be a promising strategy for a less invasive individualized surgery for early-stage esophageal cancer. These technical advances are expected to decrease the morbidity and mortality rate of surgery for esophageal cancer and hopefully improve oncological outcomes.
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